Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids
Open Access
- 14 April 2008
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 8 (5) , 984-989
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Dissociation of Depletional Induction and Posttransplant Lymphoproliferative Disease in Kidney Recipients Treated With AlemtuzumabAmerican Journal of Transplantation, 2007
- American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ TransplantationAmerican Journal of Transplantation, 2006
- Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo MalignanciesTransplantation, 2005
- Low Incidence of Malignancy among Sirolimus/Cyclosporine-Treated Renal Transplant RecipientsTransplantation, 2005
- Post-Transplant Infections Now Exceed Acute Rejection as Cause for Hospitalization: A Report of the NAPRTCSAmerican Journal of Transplantation, 2004
- Glucocorticoids and growth problemsActa Paediatrica, 1995
- POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Glucocorticoid Inhibition of Growth in Rats: Partial Reversal with Somatostatin Antibodies*Endocrinology, 1990
- EB virus antibody at different agesBMJ, 1969
- Prevalence of antibodies to EB virus and other herpesviruses1969